| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | RNA splicing | 9.63e-06 | 502 | 32 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | negative regulation of type B pancreatic cell apoptotic process | 6.49e-05 | 8 | 32 | 2 | GO:2000675 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.01e-04 | 158 | 32 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.04e-04 | 59 | 32 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.77e-04 | 551 | 32 | 6 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell apoptotic process | 2.42e-04 | 15 | 32 | 2 | GO:2000674 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.48e-04 | 79 | 32 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.84e-04 | 207 | 32 | 4 | GO:0043484 | |
| GeneOntologyBiologicalProcess | RNA processing | 3.36e-04 | 1500 | 32 | 9 | GO:0006396 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell apoptotic process | 3.51e-04 | 18 | 32 | 2 | GO:0097050 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED12L MLLT1 ATXN7L3 BPTF AFF1 PRPF38B SRRM2 DEK THRAP3 AFF4 | 2.52e-05 | 1377 | 32 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | super elongation complex | 3.39e-05 | 6 | 32 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | nuclear speck | 4.27e-05 | 431 | 32 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 4.90e-05 | 903 | 32 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 8.55e-05 | 56 | 32 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.37e-04 | 28 | 32 | 2 | GO:0000242 | |
| GeneOntologyCellularComponent | chromatin | 1.40e-03 | 1480 | 32 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | mediator complex | 1.46e-03 | 37 | 32 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | fibrillar center | 1.73e-03 | 156 | 32 | 3 | GO:0001650 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 3.09e-03 | 54 | 32 | 2 | GO:0071011 | |
| Domain | TF_AF4/FMR2 | 1.70e-05 | 4 | 32 | 2 | IPR007797 | |
| Domain | AF-4 | 1.70e-05 | 4 | 32 | 2 | PF05110 | |
| Domain | SAP | 6.43e-04 | 22 | 32 | 2 | PF02037 | |
| Domain | SAP | 7.04e-04 | 23 | 32 | 2 | SM00513 | |
| Domain | SAP | 8.32e-04 | 25 | 32 | 2 | PS50800 | |
| Domain | SAP_dom | 8.32e-04 | 25 | 32 | 2 | IPR003034 | |
| Domain | TPR_1 | 1.04e-02 | 90 | 32 | 2 | PF00515 | |
| Domain | TPR_1 | 1.04e-02 | 90 | 32 | 2 | IPR001440 | |
| Domain | ZF_PHD_2 | 1.15e-02 | 95 | 32 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.17e-02 | 96 | 32 | 2 | PS01359 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BPTF AFF1 PRPF38B PPIG SETD2 NKAP REST SRSF6 ATRX SRRM2 TCOF1 PNISR MAPT THRAP3 PCM1 CAST | 1.34e-18 | 774 | 32 | 16 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SLTM MLLT1 ATXN7L3 BPTF PPIG SETD2 REST BBX SRSF6 ATRX SRRM2 TCOF1 PNISR DEK THRAP3 | 1.04e-13 | 1294 | 32 | 15 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SLTM MLLT1 BPTF SETD2 BBX SRSF6 ATRX SRRM2 DEK THRAP3 PCM1 AFF4 CAST | 9.85e-13 | 954 | 32 | 13 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SLTM BPTF PRPF38B PPIG SETD2 BBX SRSF6 SRRM2 TCOF1 PNISR DEK THRAP3 AFF4 | 4.78e-12 | 1082 | 32 | 13 | 38697112 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | MLLT1 AFF1 PPIG SETD2 NKAP AKAP9 SRSF6 SRRM2 TCOF1 THRAP3 AFF4 | 1.65e-11 | 695 | 32 | 11 | 23602568 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.88e-11 | 361 | 32 | 9 | 26167880 | |
| Pubmed | 5.29e-10 | 713 | 32 | 10 | 29802200 | ||
| Pubmed | 6.73e-10 | 731 | 32 | 10 | 29298432 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.74e-09 | 807 | 32 | 10 | 22681889 | |
| Pubmed | MLLT1 ATXN7L3 BPTF SETD2 NKAP ZNF608 SRRM2 TCOF1 MAPT PCM1 AFF4 | 2.46e-09 | 1116 | 32 | 11 | 31753913 | |
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 2.83e-09 | 4 | 32 | 3 | 25282333 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.30e-09 | 432 | 32 | 8 | 23455922 | |
| Pubmed | 6.67e-09 | 457 | 32 | 8 | 22190034 | ||
| Pubmed | MLLT1 AFF1 PRPF38B PPIG AKAP9 SRSF6 ZNF608 SRRM2 TCOF1 THRAP3 AFF4 | 7.78e-09 | 1247 | 32 | 11 | 27684187 | |
| Pubmed | 9.27e-09 | 300 | 32 | 7 | 28561026 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.21e-08 | 989 | 32 | 10 | 36424410 | |
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 2.47e-08 | 7 | 32 | 3 | 15856011 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BPTF AFF1 PRPF38B ATRX ZNF608 MAPT THRAP3 PCM1 AFF4 CAST TTC14 | 4.80e-08 | 1489 | 32 | 11 | 28611215 |
| Pubmed | 8.45e-08 | 10 | 32 | 3 | 20153263 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 9.03e-08 | 910 | 32 | 9 | 36736316 | |
| Pubmed | 1.03e-07 | 251 | 32 | 6 | 31076518 | ||
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 24367103 | ||
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 20471949 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.20e-07 | 665 | 32 | 8 | 30457570 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.24e-07 | 259 | 32 | 6 | 30404004 | |
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 1.55e-07 | 12 | 32 | 3 | 22195968 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.55e-07 | 269 | 32 | 6 | 29511261 | |
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 2.01e-07 | 13 | 32 | 3 | 22355797 | |
| Pubmed | 2.25e-07 | 1014 | 32 | 9 | 32416067 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.39e-07 | 148 | 32 | 5 | 32538781 | |
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 25921070 | ||
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 20854876 | ||
| Pubmed | 3.75e-07 | 1429 | 32 | 10 | 35140242 | ||
| Pubmed | 4.06e-07 | 317 | 32 | 6 | 30997501 | ||
| Pubmed | 4.07e-07 | 1442 | 32 | 10 | 35575683 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.21e-07 | 341 | 32 | 6 | 32971831 | |
| Pubmed | Lost in transcription: molecular mechanisms that control HIV latency. | 6.79e-07 | 19 | 32 | 3 | 23518577 | |
| Pubmed | 7.83e-07 | 188 | 32 | 5 | 29721183 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 37528066 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24843025 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 26007649 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 9.86e-07 | 197 | 32 | 5 | 20811636 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 9.86e-07 | 197 | 32 | 5 | 22365833 | |
| Pubmed | The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency. | 1.08e-06 | 22 | 32 | 3 | 22567366 | |
| Pubmed | 1.55e-06 | 399 | 32 | 6 | 35987950 | ||
| Pubmed | 1.82e-06 | 655 | 32 | 7 | 35819319 | ||
| Pubmed | 1.91e-06 | 660 | 32 | 7 | 32780723 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.00e-06 | 1318 | 32 | 9 | 30463901 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.15e-06 | 231 | 32 | 5 | 16452087 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 16433901 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28589370 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 22767602 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 10588740 | ||
| Pubmed | 2.76e-06 | 1371 | 32 | 9 | 36244648 | ||
| Pubmed | 2.87e-06 | 245 | 32 | 5 | 21182205 | ||
| Pubmed | 2.93e-06 | 246 | 32 | 5 | 15345747 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.08e-06 | 1024 | 32 | 8 | 24711643 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 10908574 | ||
| Pubmed | Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells. | 4.92e-06 | 4 | 32 | 2 | 14578391 | |
| Pubmed | A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. | 4.92e-06 | 4 | 32 | 2 | 26830226 | |
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 4.92e-06 | 4 | 32 | 2 | 11923441 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 4.92e-06 | 4 | 32 | 2 | 15459319 | |
| Pubmed | HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold. | 4.92e-06 | 4 | 32 | 2 | 23251033 | |
| Pubmed | 5.12e-06 | 124 | 32 | 4 | 20850016 | ||
| Pubmed | 5.66e-06 | 1497 | 32 | 9 | 31527615 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.79e-06 | 283 | 32 | 5 | 30585729 | |
| Pubmed | 6.83e-06 | 40 | 32 | 3 | 28805822 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 7.36e-06 | 41 | 32 | 3 | 20431927 | |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 7.83e-06 | 138 | 32 | 4 | 37506885 | |
| Pubmed | 9.62e-06 | 549 | 32 | 6 | 38280479 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.18e-05 | 328 | 32 | 5 | 23398456 | |
| Pubmed | Protein 600 is a microtubule/endoplasmic reticulum-associated protein in CNS neurons. | 1.23e-05 | 6 | 32 | 2 | 18385319 | |
| Pubmed | Misguided transcriptional elongation causes mixed lineage leukemia. | 1.23e-05 | 6 | 32 | 2 | 19956800 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.25e-05 | 332 | 32 | 5 | 32786267 | |
| Pubmed | 1.27e-05 | 156 | 32 | 4 | 22952844 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.61e-05 | 1284 | 32 | 8 | 17353931 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.68e-05 | 353 | 32 | 5 | 27545878 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 31631027 | ||
| Pubmed | 1.73e-05 | 1297 | 32 | 8 | 33545068 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.74e-05 | 169 | 32 | 4 | 23084401 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.80e-05 | 358 | 32 | 5 | 32460013 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.84e-05 | 934 | 32 | 7 | 33916271 | |
| Pubmed | 2.04e-05 | 1327 | 32 | 8 | 32694731 | ||
| Pubmed | 2.24e-05 | 963 | 32 | 7 | 28671696 | ||
| Pubmed | Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis. | 2.29e-05 | 8 | 32 | 2 | 24648492 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 32479599 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 21873227 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 22031837 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 22483617 | ||
| Pubmed | 2.56e-05 | 653 | 32 | 6 | 22586326 | ||
| Pubmed | 2.92e-05 | 396 | 32 | 5 | 26687479 | ||
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 2.94e-05 | 9 | 32 | 2 | 24412544 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 15009664 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 24565118 | ||
| Pubmed | 2.97e-05 | 65 | 32 | 3 | 29795372 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.40e-05 | 1425 | 32 | 8 | 30948266 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.48e-05 | 411 | 32 | 5 | 35182466 | |
| Pubmed | 3.56e-05 | 203 | 32 | 4 | 35012549 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 19000783 | ||
| Pubmed | 3.77e-05 | 206 | 32 | 4 | 34185411 | ||
| Interaction | PIP4K2A interactions | SLTM MLLT1 AFF1 PRPF38B PPIG SETD2 NKAP SRRM2 TCOF1 PNISR MAPT AFF4 | 3.16e-16 | 216 | 32 | 12 | int:PIP4K2A |
| Interaction | DDX23 interactions | SLTM MLLT1 PPIG SETD2 NKAP SRSF6 SRRM2 TCOF1 PNISR THRAP3 PCM1 AFF4 TTC14 | 1.55e-13 | 480 | 32 | 13 | int:DDX23 |
| Interaction | CAMKV interactions | 1.02e-11 | 118 | 32 | 8 | int:CAMKV | |
| Interaction | SRSF6 interactions | RPF1 BPTF PRPF38B PPIG SETD2 REST BBX SRSF6 SRRM2 MAPT THRAP3 | 1.69e-10 | 503 | 32 | 11 | int:SRSF6 |
| Interaction | MECP2 interactions | SLTM RPF1 BPTF PRPF38B PPIG SETD2 BBX SRSF6 ATRX SRRM2 TCOF1 PNISR DEK THRAP3 AFF4 | 2.23e-10 | 1287 | 32 | 15 | int:MECP2 |
| Interaction | H3C1 interactions | CYLC2 MLLT1 BPTF IRF1 SETD2 BBX ATRX DEK MAPT THRAP3 AFF4 UBR4 CAST | 4.12e-10 | 901 | 32 | 13 | int:H3C1 |
| Interaction | SRPK2 interactions | SLTM PRPF38B PPIG SETD2 NKAP SRSF6 SRRM2 TCOF1 PNISR MAPT THRAP3 UBR4 | 4.41e-10 | 717 | 32 | 12 | int:SRPK2 |
| Interaction | DHX8 interactions | 5.21e-10 | 292 | 32 | 9 | int:DHX8 | |
| Interaction | SMC5 interactions | SLTM MLLT1 BPTF SETD2 BBX SRSF6 ATRX SRRM2 DEK THRAP3 PCM1 AFF4 CAST | 1.47e-09 | 1000 | 32 | 13 | int:SMC5 |
| Interaction | LUC7L interactions | 3.16e-09 | 242 | 32 | 8 | int:LUC7L | |
| Interaction | EPB41L3 interactions | 7.89e-09 | 272 | 32 | 8 | int:EPB41L3 | |
| Interaction | TERF2 interactions | 4.47e-08 | 340 | 32 | 8 | int:TERF2 | |
| Interaction | CLK3 interactions | 4.48e-08 | 220 | 32 | 7 | int:CLK3 | |
| Interaction | FGF12 interactions | 2.45e-07 | 87 | 32 | 5 | int:FGF12 | |
| Interaction | RNPS1 interactions | 2.47e-07 | 425 | 32 | 8 | int:RNPS1 | |
| Interaction | MEN1 interactions | SLTM BPTF SRSF6 ATRX ZNF608 SRRM2 TCOF1 DEK THRAP3 AFF4 UBR4 | 2.79e-07 | 1029 | 32 | 11 | int:MEN1 |
| Interaction | DENND2D interactions | 2.98e-07 | 36 | 32 | 4 | int:DENND2D | |
| Interaction | SRSF4 interactions | 3.70e-07 | 300 | 32 | 7 | int:SRSF4 | |
| Interaction | EPB41L1 interactions | 4.37e-07 | 187 | 32 | 6 | int:EPB41L1 | |
| Interaction | ZC3H18 interactions | 6.23e-07 | 877 | 32 | 10 | int:ZC3H18 | |
| Interaction | SRSF11 interactions | 7.07e-07 | 203 | 32 | 6 | int:SRSF11 | |
| Interaction | CDK12 interactions | 1.39e-06 | 228 | 32 | 6 | int:CDK12 | |
| Interaction | SNRNP70 interactions | 1.78e-06 | 984 | 32 | 10 | int:SNRNP70 | |
| Interaction | APEX1 interactions | 2.26e-06 | 1271 | 32 | 11 | int:APEX1 | |
| Interaction | NCL interactions | 2.82e-06 | 798 | 32 | 9 | int:NCL | |
| Interaction | DOT1L interactions | 3.10e-06 | 807 | 32 | 9 | int:DOT1L | |
| Interaction | SNIP1 interactions | 3.32e-06 | 417 | 32 | 7 | int:SNIP1 | |
| Interaction | CSNK2B interactions | 4.45e-06 | 625 | 32 | 8 | int:CSNK2B | |
| Interaction | MYCN interactions | SLTM PRPF38B PPIG SETD2 NKAP BBX SRSF6 SRRM2 TCOF1 DEK THRAP3 | 4.79e-06 | 1373 | 32 | 11 | int:MYCN |
| Interaction | RPS19 interactions | 5.24e-06 | 639 | 32 | 8 | int:RPS19 | |
| Interaction | CBX3 interactions | 5.68e-06 | 646 | 32 | 8 | int:CBX3 | |
| Interaction | RAD18 interactions | 6.07e-06 | 457 | 32 | 7 | int:RAD18 | |
| Interaction | MACROH2A1 interactions | 6.15e-06 | 458 | 32 | 7 | int:MACROH2A1 | |
| Interaction | PNN interactions | 7.03e-06 | 302 | 32 | 6 | int:PNN | |
| Interaction | SAP18 interactions | 7.44e-06 | 305 | 32 | 6 | int:SAP18 | |
| Interaction | CEBPB interactions | MLLT1 BPTF AFF1 NKAP AKAP9 SRSF6 SRRM2 TCOF1 DEK THRAP3 CAST | 7.72e-06 | 1443 | 32 | 11 | int:CEBPB |
| Interaction | CIT interactions | RPF1 BPTF PRPF38B AKAP9 SRSF6 SRRM2 TCOF1 DEK PLS1 THRAP3 UBR4 | 8.09e-06 | 1450 | 32 | 11 | int:CIT |
| Interaction | ELL3 interactions | 9.22e-06 | 26 | 32 | 3 | int:ELL3 | |
| Interaction | POLR1G interactions | 9.43e-06 | 489 | 32 | 7 | int:POLR1G | |
| Interaction | AURKA interactions | 9.80e-06 | 696 | 32 | 8 | int:AURKA | |
| Interaction | TTC14 interactions | 1.16e-05 | 28 | 32 | 3 | int:TTC14 | |
| Interaction | CSNK2A1 interactions | 1.22e-05 | 956 | 32 | 9 | int:CSNK2A1 | |
| Interaction | MDK interactions | 1.27e-05 | 91 | 32 | 4 | int:MDK | |
| Interaction | CLK2 interactions | 1.31e-05 | 195 | 32 | 5 | int:CLK2 | |
| Interaction | NFKBIL1 interactions | 1.38e-05 | 93 | 32 | 4 | int:NFKBIL1 | |
| Interaction | PRC1 interactions | 1.41e-05 | 973 | 32 | 9 | int:PRC1 | |
| Interaction | CPSF6 interactions | 1.51e-05 | 526 | 32 | 7 | int:CPSF6 | |
| Interaction | ANK2 interactions | 1.70e-05 | 98 | 32 | 4 | int:ANK2 | |
| Interaction | FMR1 interactions | 1.71e-05 | 536 | 32 | 7 | int:FMR1 | |
| Interaction | PLCD4 interactions | 1.75e-05 | 32 | 32 | 3 | int:PLCD4 | |
| Interaction | ELL2 interactions | 1.92e-05 | 33 | 32 | 3 | int:ELL2 | |
| Interaction | KIF21A interactions | 2.24e-05 | 105 | 32 | 4 | int:KIF21A | |
| Interaction | ELP2 interactions | 2.24e-05 | 105 | 32 | 4 | int:ELP2 | |
| Interaction | CLK1 interactions | 2.30e-05 | 219 | 32 | 5 | int:CLK1 | |
| Interaction | LYAR interactions | 2.33e-05 | 373 | 32 | 6 | int:LYAR | |
| Interaction | ATXN1 interactions | 2.38e-05 | 1039 | 32 | 9 | int:ATXN1 | |
| Interaction | MED26 interactions | 2.41e-05 | 107 | 32 | 4 | int:MED26 | |
| Interaction | RBM39 interactions | 2.43e-05 | 1042 | 32 | 9 | int:RBM39 | |
| Interaction | UBE2O interactions | 2.45e-05 | 790 | 32 | 8 | int:UBE2O | |
| Interaction | ANKRD50 interactions | 2.50e-05 | 108 | 32 | 4 | int:ANKRD50 | |
| Interaction | CSNK2A3 interactions | 2.69e-05 | 110 | 32 | 4 | int:CSNK2A3 | |
| Interaction | CD2BP2 interactions | 3.03e-05 | 232 | 32 | 5 | int:CD2BP2 | |
| Interaction | PLCD3 interactions | 3.90e-05 | 121 | 32 | 4 | int:PLCD3 | |
| Interaction | LMNB1 interactions | 3.91e-05 | 610 | 32 | 7 | int:LMNB1 | |
| Interaction | HDAC1 interactions | 3.95e-05 | 1108 | 32 | 9 | int:HDAC1 | |
| Interaction | SP110 interactions | 4.03e-05 | 122 | 32 | 4 | int:SP110 | |
| Interaction | RNF151 interactions | 4.16e-05 | 123 | 32 | 4 | int:RNF151 | |
| Interaction | DHX40 interactions | 4.24e-05 | 249 | 32 | 5 | int:DHX40 | |
| Interaction | NUP43 interactions | 4.57e-05 | 625 | 32 | 7 | int:NUP43 | |
| Interaction | VDR interactions | 4.72e-05 | 127 | 32 | 4 | int:VDR | |
| Interaction | PPIG interactions | 4.72e-05 | 127 | 32 | 4 | int:PPIG | |
| Interaction | SRSF7 interactions | 4.83e-05 | 425 | 32 | 6 | int:SRSF7 | |
| Interaction | EAF1 interactions | 4.86e-05 | 128 | 32 | 4 | int:EAF1 | |
| Interaction | ANAPC15 interactions | 4.86e-05 | 128 | 32 | 4 | int:ANAPC15 | |
| Interaction | SNRNP40 interactions | 5.15e-05 | 637 | 32 | 7 | int:SNRNP40 | |
| Interaction | NKAP interactions | 5.48e-05 | 132 | 32 | 4 | int:NKAP | |
| Interaction | PYM1 interactions | 5.65e-05 | 133 | 32 | 4 | int:PYM1 | |
| Interaction | OBSL1 interactions | 6.29e-05 | 902 | 32 | 8 | int:OBSL1 | |
| Interaction | PTTG1IP interactions | 6.38e-05 | 49 | 32 | 3 | int:PTTG1IP | |
| Interaction | BMI1 interactions | 6.39e-05 | 659 | 32 | 7 | int:BMI1 | |
| Interaction | SMARCA4 interactions | 7.67e-05 | 462 | 32 | 6 | int:SMARCA4 | |
| Interaction | FXR1 interactions | 7.71e-05 | 679 | 32 | 7 | int:FXR1 | |
| Interaction | NUPR1 interactions | 8.00e-05 | 683 | 32 | 7 | int:NUPR1 | |
| Interaction | CDK9 interactions | 8.15e-05 | 685 | 32 | 7 | int:CDK9 | |
| Interaction | IFI6 interactions | 8.54e-05 | 54 | 32 | 3 | int:IFI6 | |
| Interaction | CDK10 interactions | 8.54e-05 | 54 | 32 | 3 | int:CDK10 | |
| Interaction | RNF113A interactions | 8.68e-05 | 692 | 32 | 7 | int:RNF113A | |
| Interaction | H2BC21 interactions | 9.00e-05 | 696 | 32 | 7 | int:H2BC21 | |
| Interaction | SRPK1 interactions | 9.15e-05 | 477 | 32 | 6 | int:SRPK1 | |
| Interaction | SART3 interactions | 9.61e-05 | 296 | 32 | 5 | int:SART3 | |
| Interaction | SNRPA interactions | 9.69e-05 | 482 | 32 | 6 | int:SNRPA | |
| Interaction | DDRGK1 interactions | 1.00e-04 | 1249 | 32 | 9 | int:DDRGK1 | |
| Interaction | EPB41L2 interactions | 1.01e-04 | 299 | 32 | 5 | int:EPB41L2 | |
| Interaction | HMGB1 interactions | 1.01e-04 | 486 | 32 | 6 | int:HMGB1 | |
| Interaction | SLU7 interactions | 1.05e-04 | 156 | 32 | 4 | int:SLU7 | |
| Interaction | HTATSF1 interactions | 1.08e-04 | 157 | 32 | 4 | int:HTATSF1 | |
| Interaction | NKAPD1 interactions | 1.19e-04 | 161 | 32 | 4 | int:NKAPD1 | |
| Interaction | RSBN1 interactions | 1.19e-04 | 161 | 32 | 4 | int:RSBN1 | |
| Interaction | HERC2 interactions | 1.22e-04 | 503 | 32 | 6 | int:HERC2 | |
| Interaction | KMT2A interactions | 1.27e-04 | 314 | 32 | 5 | int:KMT2A | |
| Cytoband | 3q26.33 | 1.18e-04 | 23 | 32 | 2 | 3q26.33 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 6.93e-08 | 9 | 18 | 3 | 1280 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 5.61e-06 | 4 | 18 | 2 | 1145 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.74e-03 | 115 | 18 | 2 | 769 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.37e-02 | 181 | 18 | 2 | 694 | |
| GeneFamily | RNA binding motif containing | 1.87e-02 | 213 | 18 | 2 | 725 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BPTF IRF1 PRPF38B PPIG SETD2 REST BBX AKAP9 ATRX PNISR DEK THRAP3 PCM1 UBR4 TTC14 | 4.49e-11 | 1492 | 32 | 15 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 6.11e-08 | 656 | 32 | 9 | M18979 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.30e-07 | 363 | 32 | 7 | M41103 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 4.00e-07 | 394 | 32 | 7 | MM3724 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 6.46e-07 | 1144 | 32 | 10 | MM3843 | |
| Coexpression | TBK1.DF_DN | 1.14e-06 | 286 | 32 | 6 | M2864 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.23e-06 | 466 | 32 | 7 | M13522 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.51e-06 | 300 | 32 | 6 | M8702 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.68e-06 | 166 | 32 | 5 | M8129 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.31e-06 | 323 | 32 | 6 | M9150 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 3.99e-06 | 198 | 32 | 5 | M7228 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.56e-06 | 856 | 32 | 8 | M4500 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.02e-05 | 1215 | 32 | 9 | M41122 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 3.43e-05 | 519 | 32 | 6 | M3395 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 4.41e-05 | 543 | 32 | 6 | MM997 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 5.45e-05 | 171 | 32 | 4 | M5655 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.66e-05 | 180 | 32 | 4 | M8239 | |
| Coexpression | WANG_LMO4_TARGETS_DN | 7.15e-05 | 361 | 32 | 5 | M12674 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 8.54e-05 | 612 | 32 | 6 | MM3804 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 9.41e-05 | 911 | 32 | 7 | M40038 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 9.62e-05 | 198 | 32 | 4 | M5419 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 9.81e-05 | 199 | 32 | 4 | M6839 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 9.81e-05 | 199 | 32 | 4 | M3846 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M9472 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.00e-04 | 200 | 32 | 4 | M9449 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.12e-04 | 206 | 32 | 4 | M39254 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.23e-04 | 79 | 32 | 3 | M7102 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.60e-04 | 429 | 32 | 5 | M29 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.81e-04 | 90 | 32 | 3 | M39250 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 2.02e-04 | 240 | 32 | 4 | MM3678 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 2.73e-04 | 481 | 32 | 5 | M3898 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 3.82e-04 | 807 | 32 | 6 | M16651 | |
| Coexpression | ALONSO_METASTASIS_DN | 4.61e-04 | 26 | 32 | 2 | M17331 | |
| Coexpression | CHICAS_RB1_TARGETS_SENESCENT | 5.69e-04 | 565 | 32 | 5 | M2125 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.04e-09 | 629 | 32 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.50e-08 | 311 | 32 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.11e-07 | 989 | 32 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SLTM BPTF PRPF38B PPIG AKAP9 ATRX TCOF1 PNISR DEK THRAP3 PCM1 TTC14 | 1.31e-07 | 1257 | 32 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.35e-07 | 831 | 32 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.77e-07 | 192 | 32 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SLTM BPTF PRPF38B PPIG AKAP9 ATRX TCOF1 PNISR DEK THRAP3 PCM1 TTC14 | 6.56e-07 | 1459 | 32 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.16e-06 | 989 | 32 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SLTM AFF1 PRPF38B PPIG AKAP9 ATRX TCOF1 DEK THRAP3 PCM1 TTC14 | 1.17e-06 | 1252 | 32 | 11 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.41e-06 | 564 | 32 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.12e-06 | 469 | 32 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.12e-06 | 186 | 32 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 2.18e-05 | 819 | 32 | 8 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.94e-05 | 291 | 32 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.77e-05 | 298 | 32 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 8.71e-05 | 498 | 32 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.15e-04 | 524 | 32 | 6 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.32e-04 | 780 | 32 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 1.35e-04 | 1060 | 32 | 8 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 1.36e-04 | 1370 | 32 | 9 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | 1.37e-04 | 1371 | 32 | 9 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.62e-04 | 806 | 32 | 7 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 1.73e-04 | 1414 | 32 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.91e-04 | 192 | 32 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.27e-04 | 375 | 32 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.30e-04 | 595 | 32 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 3.97e-04 | 1241 | 32 | 8 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.36e-04 | 432 | 32 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100 | 4.99e-04 | 22 | 32 | 2 | gudmap_developingGonad_e16.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.13e-04 | 249 | 32 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | 5.30e-04 | 979 | 32 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.69e-04 | 256 | 32 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.94e-04 | 259 | 32 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 6.99e-04 | 26 | 32 | 2 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.04e-04 | 271 | 32 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.44e-04 | 275 | 32 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 7.86e-04 | 492 | 32 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 7.86e-04 | 492 | 32 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.13e-04 | 122 | 32 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.11e-03 | 801 | 32 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 1.20e-03 | 1468 | 32 | 8 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | 1.47e-03 | 1164 | 32 | 7 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.57e-03 | 39 | 32 | 2 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.87e-03 | 163 | 32 | 3 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.42e-03 | 379 | 32 | 4 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.56e-03 | 385 | 32 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.76e-03 | 654 | 32 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | e9.5_OticVesic_top-relative-expression-ranked_500 | 2.83e-03 | 396 | 32 | 4 | Facebase_ST1_e9.5_OticVesic_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#1_top-relative-expression-ranked_500 | 3.00e-03 | 54 | 32 | 2 | gudmap_developingKidney_e15.5_cortic collect duct_500_k1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.45e-14 | 200 | 32 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.17e-12 | 198 | 32 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-11 | 188 | 32 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.10e-11 | 192 | 32 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.51e-11 | 197 | 32 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.13e-11 | 199 | 32 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.61e-09 | 192 | 32 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.76e-09 | 193 | 32 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.55e-09 | 198 | 32 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.72e-09 | 199 | 32 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 184 | 32 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-07 | 185 | 32 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-07 | 187 | 32 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.66e-07 | 195 | 32 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-07 | 195 | 32 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.73e-07 | 196 | 32 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.85e-06 | 138 | 32 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.93e-06 | 166 | 32 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 170 | 32 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-06 | 176 | 32 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 178 | 32 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 185 | 32 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.89e-06 | 189 | 32 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 192 | 32 | 4 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 192 | 32 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-05 | 193 | 32 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.07e-05 | 193 | 32 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-05 | 194 | 32 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 194 | 32 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 195 | 32 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 195 | 32 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.14e-05 | 196 | 32 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.14e-05 | 196 | 32 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.16e-05 | 197 | 32 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 197 | 32 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-05 | 198 | 32 | 4 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.21e-05 | 199 | 32 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.21e-05 | 199 | 32 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.21e-05 | 199 | 32 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.21e-05 | 199 | 32 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.21e-05 | 199 | 32 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.24e-05 | 200 | 32 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.40e-04 | 141 | 32 | 3 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.10e-04 | 162 | 32 | 3 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 163 | 32 | 3 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 163 | 32 | 3 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 163 | 32 | 3 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 169 | 32 | 3 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 169 | 32 | 3 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 04c278ad22e32a4f75af92fc9bfe439363c04f90 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 6d80795f96aac11fec1c946d1f2d16cfe6e38d9a | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.01e-04 | 183 | 32 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 7406a9fdd5beb2777a9cad3268673977bb19f050 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.21e-04 | 187 | 32 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-04 | 188 | 32 | 3 | 0a47de24812c619f6756c9351a413b109128d54f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | bab0fe55643d3ee750355a32b1ff6634fa5cf88d | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-04 | 190 | 32 | 3 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | Severe-B_activate-7|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.36e-04 | 190 | 32 | 3 | 67e6c8a5a8724bdf2861fd76a711319dfc71d47a | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.36e-04 | 190 | 32 | 3 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | d45b6aa64667d29ac043c3987902e7f7ddbcf940 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-04 | 191 | 32 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 3.46e-04 | 192 | 32 | 3 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 3916de42b9a626b5679ca98057d6e69f146b2810 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 49a34b55788d7ca955936fff1c0501ed674a9f3c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 4274c95cedad2ae8c6693ad00deda2b1ba5b5682 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | e1eee31db283aa49568b50f2ddd99f0054c99fbe | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | 61b59f8e2c68851d827b058cf03904f8125e8047 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 3.62e-04 | 195 | 32 | 3 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.68e-04 | 196 | 32 | 3 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 197 | 32 | 3 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.73e-04 | 197 | 32 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.19e-06 | 49 | 27 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.72e-06 | 50 | 27 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 49 | 27 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of DDX5 | 5.08e-04 | 63 | 27 | 3 | GNF2_DDX5 | |
| Drug | Chloroprene | SLTM BPTF IRF1 PPIG NKAP BBX AKAP9 ATRX SRRM2 PNISR DEK AFF4 | 1.32e-07 | 1348 | 32 | 12 | ctd:D002737 |
| Drug | testosterone enanthate | 9.71e-07 | 575 | 32 | 8 | ctd:C004648 | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 7.31e-06 | 195 | 32 | 5 | 1132_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.49e-06 | 196 | 32 | 5 | 3233_DN | |
| Drug | AC1LAXDH | 1.91e-05 | 5 | 32 | 2 | CID000497256 | |
| Drug | AC1L1HZ7 | 2.79e-05 | 42 | 32 | 3 | CID000004355 | |
| Drug | Succimer | 4.27e-05 | 1264 | 32 | 9 | ctd:D004113 | |
| Drug | Magnetite Nanoparticles | 5.65e-05 | 1310 | 32 | 9 | ctd:D058185 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.05e-04 | 176 | 32 | 4 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.05e-04 | 176 | 32 | 4 | 1535_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.07e-04 | 177 | 32 | 4 | 985_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.09e-04 | 178 | 32 | 4 | 7245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.09e-04 | 178 | 32 | 4 | 5086_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.12e-04 | 179 | 32 | 4 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.19e-04 | 182 | 32 | 4 | 1951_DN | |
| Drug | AG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 1.32e-04 | 187 | 32 | 4 | 1141_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.47e-04 | 192 | 32 | 4 | 2722_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.47e-04 | 192 | 32 | 4 | 7427_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.47e-04 | 192 | 32 | 4 | 3252_DN | |
| Drug | dimethylthioarsinic acid | 1.48e-04 | 13 | 32 | 2 | ctd:C547156 | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4662_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 7413_UP | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 4706_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 1.55e-04 | 195 | 32 | 4 | 1956_DN | |
| Drug | geldanamycin | 1.57e-04 | 371 | 32 | 5 | ctd:C001277 | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 7311_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 7275_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3292_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 1701_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4729_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 1.68e-04 | 199 | 32 | 4 | 122_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; HL60; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 1862_UP | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6806_DN | |
| Drug | chlorpropamide; Down 200; 100uM; MCF7; HG-U133A | 1.71e-04 | 200 | 32 | 4 | 141_DN | |
| Drug | Dronabinol | 2.16e-04 | 905 | 32 | 7 | ctd:D013759 | |
| Drug | chlorcyclizine | 2.47e-04 | 87 | 32 | 3 | ctd:C084597 | |
| Drug | all M | 2.55e-04 | 88 | 32 | 3 | CID000004331 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.44e-04 | 17 | 31 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | monocyte count | 3.61e-04 | 1320 | 31 | 7 | EFO_0005091 | |
| Disease | Bilateral Wilms Tumor | 4.26e-04 | 29 | 31 | 2 | C2930471 | |
| Disease | brain ischemia (implicated_via_orthology) | 6.22e-04 | 35 | 31 | 2 | DOID:2316 (implicated_via_orthology) | |
| Disease | Nephroblastoma | 6.58e-04 | 36 | 31 | 2 | C0027708 | |
| Disease | Growth Disorders | 6.58e-04 | 36 | 31 | 2 | C0018273 | |
| Disease | Cognition Disorders | 7.33e-04 | 38 | 31 | 2 | C0009241 | |
| Disease | eosinophil count | 7.39e-04 | 1488 | 31 | 7 | EFO_0004842 | |
| Disease | Intellectual Disability | 1.18e-03 | 447 | 31 | 4 | C3714756 | |
| Disease | triglycerides in LDL measurement | 1.59e-03 | 56 | 31 | 2 | EFO_0022320 | |
| Disease | triglycerides in small VLDL measurement | 1.88e-03 | 61 | 31 | 2 | EFO_0022145 | |
| Disease | triglycerides in medium LDL measurement | 1.94e-03 | 62 | 31 | 2 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.94e-03 | 62 | 31 | 2 | EFO_0022339 | |
| Disease | triglycerides in small HDL measurement | 1.94e-03 | 62 | 31 | 2 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.94e-03 | 62 | 31 | 2 | EFO_0022169 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTTRSKSKERKKSKS | 211 | Q13523 | |
| KSKERKKSKSPSKRS | 216 | Q13523 | |
| SPSKKQKKKRKTSSS | 31 | Q99996 | |
| QKKKRKTSSSKHDVS | 36 | Q99996 | |
| KKMSKEKSSDTTKES | 536 | Q8WY36 | |
| KKDKKKPSSTDSDSK | 271 | Q14093 | |
| SSKSKKKKMISTTSK | 2846 | Q12830 | |
| NSSESRKTKKKKSHL | 301 | Q14CW9 | |
| EKKKYKSTSKSSQKS | 626 | Q9UHB7 | |
| KERKSKSSRDAKSKA | 121 | P10914 | |
| KSSRDAKSKAKRKSC | 126 | P10914 | |
| TGSNSEKFSKTKKSK | 506 | Q13127 | |
| KKTKGRKRKTKSSSR | 1766 | Q86YW9 | |
| KRKDKASASSSAKKR | 931 | Q5VYM1 | |
| KDKTPKSKSKKRNST | 1291 | Q15154 | |
| KSANKKTSISSFKDK | 531 | Q14651 | |
| KKSEPSSKTSSLKKK | 126 | Q8IYB4 | |
| KKRKKSKKSASSESE | 246 | Q13427 | |
| AKSKSRSKSKEKSKS | 456 | Q13427 | |
| RSKSKEKSKSKERDS | 461 | Q13427 | |
| DTKKGKSAKSSIISK | 791 | P46100 | |
| SKKTCSKGSKKERNS | 196 | P35659 | |
| KQKATSKSKKSVKSA | 266 | P35659 | |
| TAKDKCKKAASSSKA | 671 | P20810 | |
| SAKKQKKSSSKGSRS | 296 | Q03111 | |
| STSEEEKKKKSSRSK | 176 | Q8N5F7 | |
| KKRSKKSRKESSDSS | 251 | Q8N5F7 | |
| KSSKKKKHRSESESK | 211 | Q9UQ35 | |
| KTSTTSKGKAKRDKA | 1381 | Q13428 | |
| SSEKSEKKESKDTKK | 506 | Q9NWH9 | |
| SRSKGRKSRSKSKSK | 236 | Q13247 | |
| KRSSDSSSKLAKKRK | 801 | P51825 | |
| DKSSSSGKKSLKRKA | 6 | Q9H9Y2 | |
| SSKRKSAKEKKSSSK | 171 | Q9Y2W1 | |
| KRSRSRSKEKSSKHK | 446 | Q5VTL8 | |
| KKAKTSTRSSAKTLK | 391 | P10636 | |
| KRLKKKRRKSTSSSS | 466 | Q96N46 | |
| SCKKTGSKKKSSQSE | 301 | Q9BYW2 | |
| NSHKETSKSKVKRSK | 96 | Q9ULD9 | |
| TSKSKVKRSKTSKDA | 101 | Q9ULD9 | |
| SRQDSKKSTTKDSKK | 736 | Q8TF01 | |
| TQSKSSTKKSKKEEK | 3361 | Q5T4S7 |